Home/Pipeline/NEU001

NEU001

Nasopharyngeal Carcinoma

Phase 1Active

Key Facts

Indication
Nasopharyngeal Carcinoma
Phase
Phase 1
Status
Active
Company

About NeuCen Biomedical

Taiwan biotech delivering nasal drug‑delivery platforms for allergy and oncology.

View full company profile

Therapeutic Areas